These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 26800130

  • 1. Effects of probucol on left atrial remodeling in patients with paroxysmal atrial fibrillation.
    Shao Q, Korantzopoulos P, Fu H, Ye L, Liu E, Xu G, Li G, Liu T.
    Int J Cardiol; 2016 Mar 15; 207():117-9. PubMed ID: 26800130
    [No Abstract] [Full Text] [Related]

  • 2. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
    Fu H, Li G, Liu C, Li J, Wang X, Cheng L, Liu T.
    J Cardiovasc Electrophysiol; 2015 Feb 15; 26(2):211-22. PubMed ID: 25199622
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model.
    Fu H, Li G, Liu C, Li J, Cheng L, Yang W, Tse G, Zhao J, Liu T.
    Oncotarget; 2016 Dec 20; 7(51):83850-83858. PubMed ID: 27863381
    [Abstract] [Full Text] [Related]

  • 5. Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs.
    Li Y, Sheng L, Li W, Liu W, Gong Y, Xue H, Shan H.
    Biochem Biophys Res Commun; 2009 Apr 03; 381(2):198-203. PubMed ID: 19338773
    [Abstract] [Full Text] [Related]

  • 6. Defining the role of oxidative stress in atrial fibrillation and diabetes.
    Ziolo MT, Mohler PJ.
    J Cardiovasc Electrophysiol; 2015 Feb 03; 26(2):223-5. PubMed ID: 25298131
    [No Abstract] [Full Text] [Related]

  • 7. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing.
    Gong YT, Li WM, Li Y, Yang SS, Sheng L, Yang N, Shan HB, Xue HJ, Liu W, Yang BF, Dong DL, Li BX.
    Chin Med J (Engl); 2009 Jan 05; 122(1):74-82. PubMed ID: 19187621
    [Abstract] [Full Text] [Related]

  • 8. Serum Soluble Semaphorin 4D is Associated with Left Atrial Diameter in Patients with Atrial Fibrillation.
    Xiang L, You T, Chen J, Xu W, Jiao Y.
    Med Sci Monit; 2015 Sep 29; 21():2912-7. PubMed ID: 26417899
    [Abstract] [Full Text] [Related]

  • 9. Impact of asymmetrical dilatation of the left atrium on the long-term success after catheter ablation of atrial fibrillation.
    Nedios S, Koutalas E, Kosiuk J, Sommer P, Arya A, Richter S, Rolf S, Husser D, Hindricks G, Bollmann A.
    Int J Cardiol; 2015 Apr 01; 184():315-317. PubMed ID: 25731848
    [No Abstract] [Full Text] [Related]

  • 10. Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.
    Zhang Q, Liu T, Ng CY, Li G.
    Cardiovasc Ther; 2014 Oct 01; 32(5):233-41. PubMed ID: 25065462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Left atrial appendage ligation in patients with atrial fibrillation leads to a decrease in atrial dispersion.
    Kawamura M, Scheinman MM, Lee RJ, Badhwar N.
    J Am Heart Assoc; 2015 May 14; 4(5):. PubMed ID: 25977469
    [Abstract] [Full Text] [Related]

  • 13. Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.
    Sirish P, Li N, Timofeyev V, Zhang XD, Wang L, Yang J, Lee KS, Bettaieb A, Ma SM, Lee JH, Su D, Lau VC, Myers RE, Lieu DK, López JE, Young JN, Yamoah EN, Haj F, Ripplinger CM, Hammock BD, Chiamvimonvat N.
    Circ Arrhythm Electrophysiol; 2016 May 14; 9(5):. PubMed ID: 27162031
    [Abstract] [Full Text] [Related]

  • 14. [Probucol].
    Ayaori M, Ogura M, Kusuhara M.
    Nihon Rinsho; 2007 Jul 28; 65 Suppl 7():470-5. PubMed ID: 17824073
    [No Abstract] [Full Text] [Related]

  • 15. [HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
    Snezhitsky VA, Yatskevich ES, Doroshenko EM, Smirnov VY, Dolgoshey TS, Rubinsky AY.
    Klin Med (Mosk); 2016 Jul 28; 94(1):16-22. PubMed ID: 27172716
    [Abstract] [Full Text] [Related]

  • 16. [Influence of oxidative stress on atrial myocardium pathohistological and ultrastructural changes in atrial fibrillation: experiment with dogs].
    Li WM, Sheng L, Li Y, Yang BF, Gong YT, Xue HJ, Yu JB, Zhang L, Shan HB, Liu J.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):985-9. PubMed ID: 18756973
    [Abstract] [Full Text] [Related]

  • 17. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors.
    Sciacqua A, Perticone M, Tripepi G, Miceli S, Tassone EJ, Grillo N, Carullo G, Sesti G, Perticone F.
    Int J Cardiol; 2014 Jul 15; 175(1):90-5. PubMed ID: 24836687
    [Abstract] [Full Text] [Related]

  • 18. Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation.
    Sasaki N, Okumura Y, Watanabe I, Nagashima K, Sonoda K, Kogawa R, Takahashi K, Iso K, Ohkubo K, Nakai T, Hiro T, Hirayama A.
    Int J Cardiol; 2014 Oct 20; 176(3):1064-6. PubMed ID: 25129276
    [No Abstract] [Full Text] [Related]

  • 19. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
    Liu T, Zhao H, Li J, Korantzopoulos P, Li G.
    Cardiovasc Ther; 2014 Aug 20; 32(4):178-83. PubMed ID: 24814361
    [Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.
    van Hunnik A, Lau DH, Zeemering S, Kuiper M, Verheule S, Schotten U.
    Heart Rhythm; 2016 Apr 20; 13(4):964-72. PubMed ID: 26681610
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.